Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.11604/pamj.2020.37.124.24973 http://scihub22266oqcxt.onion/10.11604/pamj.2020.37.124.24973 33425157!7755367!33425157     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Pan+Afr+Med+J 2020 ; 37 (ä): 124 Nephropedia Template TP {{tp|p=33425157|t=2020. A review of COVID-19 vaccines in development: 6 months into the pandemic |pdf=|usr=}}{{33425157}} gab.com Text A review of COVID-19 vaccines in development: 6 months into the pandemic JO: Pan Afr Med J http://www.kidney.de/pget.php?&tw=1&pmid=33425157 #FOAvip The advent of the COVID-19 pandemic and the dynamics of its spread is unprecedented. Therefore, the need for a vaccine against the virus is huge. Researchers worldwide are working around the clock to find a vaccine. Experts estimate that a fast-tracked vaccine development process could speed a successful candidate to market in approximately 12-18 months. The objective of this review was to describe the coronavirus vaccines candidates in development and the important considerations. The review was conducted through a thematic analysis of the literature on COVID-19 vaccines in development. It only included data until the end of June 2020, 6 months after the emergence of the COVID-19. Different approaches are currently used to develop COVID-19 vaccines from traditional live-attenuated, inactivated, subunit vaccines, to more novel technologies such as DNA or mRNA vaccines. The race is on to find both medicines and vaccines for the COVID-19 pandemic. As with drugs, vaccine candidates go through pre-clinical testing first before they go through the three phases of clinical trials in humans. Of the over 130 vaccine candidates, 17 are in clinical trials while others are expected to move to clinical testing after the animal studies. Twit Text FOAVip A review of COVID-19 vaccines in development: 6 months into the pandemic ????Pan Afr Med J http://www.kidney.de/pget.php?&tw=1&pmid=33425157 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33425157 #FOAvip English Wikipedia <ref>{{Cite pmid|33425157}}</ref> A review of COVID-19 vaccines in development: 6 months into the pandemic #MMPMID33425157 Sanicas M; Sanicas M; Diop D; Montomoli E Pan Afr Med J 2020[]; 37 (ä): 124 PMID33425157show ga The advent of the COVID-19 pandemic and the dynamics of its spread is unprecedented. Therefore, the need for a vaccine against the virus is huge. Researchers worldwide are working around the clock to find a vaccine. Experts estimate that a fast-tracked vaccine development process could speed a successful candidate to market in approximately 12-18 months. The objective of this review was to describe the coronavirus vaccines candidates in development and the important considerations. The review was conducted through a thematic analysis of the literature on COVID-19 vaccines in development. It only included data until the end of June 2020, 6 months after the emergence of the COVID-19. Different approaches are currently used to develop COVID-19 vaccines from traditional live-attenuated, inactivated, subunit vaccines, to more novel technologies such as DNA or mRNA vaccines. The race is on to find both medicines and vaccines for the COVID-19 pandemic. As with drugs, vaccine candidates go through pre-clinical testing first before they go through the three phases of clinical trials in humans. Of the over 130 vaccine candidates, 17 are in clinical trials while others are expected to move to clinical testing after the animal studies. |*COVID-19 Vaccines[MESH] |*Drug Development[MESH] |Animals[MESH] |COVID-19/*prevention & control[MESH] |Clinical Trials as Topic[MESH] |Humans[MESH]A review of COVID-19 vaccines in development: 6 months into the pandem(epmc).pdf DeepDyve Pubget Overpricing